NFKB1 and colorectal carcinoma: Collectively, the results of the above preclinical trial demonstrate that falcarinol and falcarindiol in combination have a dose-dependent chemopreventive effect on neoplastic lesions in a rat model of CRC, and that this effect is most likely due to inhibition of downstream proinflammatory markers in the NF-κB signaling pathway.